71 results
8-K
EX-99.1
KA
Kineta Inc
16 Aug 21
Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants
7:21am
, with 25 percent of the shares vesting on the first anniversary of Mr. Wyzga’s new hire date and the remainder vesting in equal monthly installments over … over four years, with 25 percent of the shares vesting on the first anniversary of the employee’s new hire date and the remainder vesting in equal
8-K
EX-10.1
KA
Kineta Inc
16 Aug 21
Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants
7:21am
of the Company’s common stock (“New Hire Award”). The New Hire Award shall vest over four years, with twenty-five percent of the New Hire Award … anniversary of your start date, subject to your continued employment with the Company. The New Hire Award shall be granted in the form of a non-qualified
10-Q
aidnjd 3zxi7yqg8
13 May 16
Quarterly report
12:00am
8-K
EX-99.5
xi8l0o9kjwpq58 lf
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
otoi 5f2v93tf8tae
12 Jun 23
Prospectus supplement
5:01pm
424B3
2simu6bp2i
13 Nov 23
Prospectus supplement
5:28pm
8-K
EX-99.4
ksi471xq8m9ci
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm